This clinical study is conducted at one study site and in 165 women with visible signs of skin aging. It compares after 13 weeks the benefit of a combined oral collagen supplement and topical collagen serum regimen compared with oral collagen alone and topical collagen serum alone in reducing in women presenting visible signs of skin ageing .
Participant having signed an Informed Consent Form (ICF) before any trial related activity is carried out;
Female participant;
Participant with a Fitzpatrick skin type I to III;
Participant aged 45 to 60 years inclusive at the time of signing the ICF;
Participant who is pregnant or who is breast feeding;
Participant receiving hormone replacement therapy (HRT).
Participant who smokes more than two cigarettes per week;
Participant whose alcohol intake exceeds 2 drinks per week;
Vichy Laboratoires
Lead sponsor
CPCAD GIE
Collaborator
SKINPHARMA
Collaborator